Vertex Growth, a subsidiary of Temasek, has invested €10 million in Dolphin Semiconductor, a provider of semiconductor IP solutions. Vertex joins existing investor Jolt Capital, which in 2024 acquired ...

“Just plug and play.” When a hyperscaler buys AI chips, installation requires technical expertise—skills that are in short supply, Park posits. Very few chip companies go beyond selling the ...

By Tony Romm Ana Swanson and Tripp Mickle President Trump signaled on Sunday that he would pursue new tariffs on the powerful computer chips inside smartphones and other technologies, just two ...

“We wanted to uncomplicate it from a lot of other companies, because we want to make our chips and semiconductors and other things in our country,” Trump told reporters aboard Air Force One as ...

Federal notices put online Monday afternoon said the administration had initiated national security investigations into imports of chips and pharmaceuticals. Mr. Trump has suggested that those ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

BOSTON, April 11, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Microsoft's latest mandatory security update for Windows 11, KB5055523, is causing big problems for quite a few users. Reports verified by Windows Latest say that the update fails to install for ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...